M
e di c a l t e c h n o l o gy is a major driver of health care costs. The inexorable development of increasingly sophisticated innovations all but ensures that costs will continue to rise. 1 The economic and health implications of medical advances are widely debated. Some studies find that the benefits of spending on technology are well worth the costs, while others identify innovations that hold considerably less value. [2] [3] [4] Researchers have also expressed concern about technological innovations that have proved beneficial but whose use spreads too slowly, as well as those whose benefits are unverified but may be spreading too rapidly. [5] [6] [7] In this study we focus on the latter scenario in the context of 64-slice computed tomography (CT). This technology has attracted major attention because of its coronary CT angiography capabilities-despite mixed evidence on its clinical and cost-effectiveness. [8] [9] [10] 
64-Slice CT And Coronary CT Angiography
The 64-slice CT was first made publicly available by the Toshiba Corporation in the summer of 2004, but other manufacturers followed soon after. 11 Siemens introduced its model in December 2004 12 , and General Electric and Philips followed with theirs in April 2005. 13 Despite their high price tag of $1.5-$2 million, 64-slice CTs have been diffusing rapidly through health care markets. In 2005, 18 percent of nonrural general hospitals owned a 64-slice CT, and an additional 11 percent purchased the device in 2006.
14 n Capabilities and potential. Coronary CT angiography is a technique in which the coronary arteries are imaged. The 64-slice CT is the first scanner to digitally reproduce this anatomy with a level of detail that is diagnostically relevant and clinically actionable. Many physicians believe that coronary CT angiography will improve clinical care and decision making, and there is some evidence to support this assertion. 10, 15, 16 Some have even suggested that in certain clinical settings, the procedure could eventually supplant conventional diagnostic cardiac catheterization-a riskier and more expensive procedure than CT, in which a catheter is actually inserted into arteries to probe for blockages. 8, 17 These researchers base their conclusion on reports that CT angiography is more than 95 percent as effective as cardiac catheterization in diagnosing blockages. 18 The media have helped fuel the enthusiasm for the new technology's coronary angiography capabilities, and even TV personality Oprah Winfrey extolled its benefits and underwent the procedure on her show. 19 n Possible downsides. Nonetheless, coronary CT angiography is controversial. 8, 9, 20 The procedure's detractors argue that it may raise cancer risk by exposing patients to high radiation doses and, by uncovering incidental findings, could lead to additional diagnostic tests, costs, and stress for patients. [21] [22] [23] [24] Moreover, there is little evidence to support any incremental health benefit associated with use of the technology. 25 In fact, in December 2007 the Centers for Medicare and Medicaid Services (CMS) proposed restricting Medicare reimbursement of coronary CT angiography to only two indications and to only patients enrolled in clinical studies, because it found the evidence for performing coronary CT angiography insufficient. In response to pressure from advocacy groups and others, the CMS withdrew its coverage determination proposal and retained its policy of relegating coverage decisions to local Medicare carriers. 26 Researchers have also expressed broader concerns over the rapid growth of imaging tests, their clinical value, and cost. 27, 28 Between 1999 and 2004, growth in the volume of imaging services provided to Medicare beneficiaries outpaced growth rates of other services, including major procedures, office and hospital visits, and nonimaging tests. 28 Spending on diagnostic imaging technologies, including out-of-pocket and insurance payments, was estimated to be $100 billion in 2004, up from $65-$75 billion only four years earlier. 27, 28 
Why Hospitals Adopt New Technologies
Researchers have attributed hospitals' acquisition of technology to multiple motivations, including the desire to improve clinical care, competitive pressure from neighboring hospitals, profit seeking in an environment of favorable insurer reimbursement, and availability of capital needed to adopt these technologies. 5, 29, 30 We loosely extrapolate from these themes and posit that 64-slice CT is more likely to be adopted by hospitals that treat more patients with cardiac disease, function in more competitive markets, operate in states with a higher rate of insurance reimbursement for coronary CT angiography, and have higher operating margins.
A hospital's cardiac disease patient burden is related to 64-slice CT adoption because these hospitals are best poised to apply coronary CT angiography to clinical problems. These include the triage of patients with acute chest pain in the emergency department (ED), the referral of patients for stress testing or cardiac catheterization, and evaluation of the viability of coronary grafts and stents. 31 Market competition also plays a key role. Hospitals in highly competitive markets may engage in "technology races" to attract physicians, who often prefer hospitals with advanced technology. Patients, moreover, often want access to high-tech medical care. [32] [33] [34] [35] [36] Insurance reim-bursement for coronary CT angiography also gives hospitals an incentive to adopt 64-slice CT by reducing their costs associated with its application. 29, 34 Finally, high hospital margins may promote adoption that is independent of clinical need and other factors. 29 Study Data And Methods (1990, 2000) ; and personal communications with representatives from the American College of Cardiology, the American College of Radiology, and the radiological imaging industry.
n Admissions. Ischemic heart disease admission data were derived from the Medicare provider analysis, which summarizes claims data from beneficiaries admitted to Medicarecertified hospitals. Data on local Medicare carrier and Blue Cross Blue Shield coverage decisions at the state level were provided by the colleges of cardiology and radiology. 39 We supplemented their findings with our own searches on the CMS and Blue Cross Blue Shield Web sites and also contacted Blues personnel in several states.
n Hospital revenue and costs. Data on hospital revenue and costs were extracted from the CMS's cost report information system. Data on certificate-of-need laws were from analyses of regulations and statutes in each state and from follow-up interviews with state regulators. Because few rural hospitals own 64-slice CT (5 percent by 2006), we limited our sample to nonrural ("micropolitan" and metropolitan), nonfederal general hospitals, and we also excluded specialty hospitals.
n Imputations and omissions. When variables were missing, we imputed their values using the surrounding years; when data for the surrounding years were also missing, we omitted the observation from our analysis. Out of roughly 3,500 hospitals that met our inclusion criteria, we omitted 660 hospitals (19 percent) for not reporting 64-slice CT ownership; an additional 270 (8 percent) for not reporting positron emission tomography (PET) ownership; 80 (2 percent) for not reporting coronary artery bypass grafting (CABG), cardiac catheterization, or older-generation multi-slice CT ownership; and an additional 80 (2 percent) because their data on ischemic heart disease admissions were incomplete.
n Analysis. We analyzed our raw data using the Pearson chi-square and KolmogorovSmirnov tests, and we built a Probit model to predict the probability that a hospital adopted 64-slice CT in or before 2006. In sensitivity analyses, we constructed a model to test for competitively driven adoption, and we also used an instrumental variable technique to further control for bias. We generally relied on independent variables from 2004 to reduce some of the bias that would otherwise exist from using contemporaneous covariates.
In our assessment of cardiac care, we included the total number of ischemic heart disease patients a hospital admits annually, and whether or not the hospital provided major cardiac services, including CABG and cardiac catheterization. The competitiveness of a hospital's market was measured by the Herfindahl-Hirschman Index, an index that is calculated at the Hospital Referral Region level-a geographic measure of a hospital's potential patient population-by summing the square of each hospital's share of admissions within its referral region. Thus, more competitive markets have smaller HerfindahlHirschman Index values. We added a variable for PET ownership in 1997 to identify hospitals that might be considered "first movers" or "technological leaders." 40 We chose 1997 because PET ownership was low prior to 1998, in part because of constraints related to access to cyclotrons (devices that produce the radionuclides needed for PET imaging), and in part because Medicare started reimbursing PET imaging in 1998. 41 Insurance reimbursement was represented by the presence or absence of coronary CT angiography coverage by either Blue Cross Blue Shield or Medicare. 29, 42 We used Blues coverage as a proxy for private insurance coverage because nearly all states have only one Blue company, and because the Blues are the largest private insurer nationwide, covering more than 100 million Americans. Blue Cross Blue Shield coverage data were provided by the American College of Cardiology and American College of Radiology, and we contacted local Blues plans for states with missing data.
Hospitals' operating margins were calculated as the quotient of net income from patient services and net patient revenue. We also included data on whether hospitals were members of hospital systems because these hospitals may (1) have a different technologyadoption decision-making process than freestanding hospitals, and (2) access capital more readily through pooled resources, capital markets, or debt. 6, 43 We considered other control variables that may influence technology acquisition decisions. These included hospital ownership (nonprofit, for-profit, or government); size, as measured by total annual admissions; teaching status, as determined by membership in the Council of Teaching Hospitals and Health Systems or the presence of a residency program certified by the Accreditation Council for Graduate Medical Education; and market characteristics, including a marker for geographic region and a collection of demographic variables measured at the censusblock level: size of population and patients' sex, ethnicity, age, education, travel time to work (a proxy for willingness to travel for medical care), employment industry (a proxy for insurance), per capita income, and household income.
The demographic variables were constructed according to a method developed by Jill Horwitz and Austin Nichols, which identifies each hospital's longitude and latitude and, based on the distance from the hospital to each census block, calculates a weighted average for the demographic information for the census block. 44 We also noted whether a hospital resided in a state with certificate-of-need laws and active regulation of adoption, thus identifying hospitals that were required to obtain permission from a state agency before acquiring 64-slice CT. Because hospitals with oldergeneration multislice CT scanners may be poised to replace their devices with newer models, and because some hospitals may value multislice CT technology more than others, we included an indicator variable for an existing multislice CT scanner on the hospital premises. In our model analysis, we adjusted for heteroskedasticity, or an irregular scattering of values and variances in distribution, with robust estimates of variance and clustered standard errors by hospital regions.
n Sensitivity analysis. Our first analysis examined adoption through 2006, which includes the few hospitals that likely adopted the technology in 2004 and the remaining hospitals that adopted it in 2005 or 2006. To determine whether the reasons for adoption differed by year of adoption, we performed a second analysis limiting the sample to hospitals that only adopted the technology in 2006 and had not adopted it prior to this year. In addition, to evaluate whether hospitals are more likely to adopt if their competitors do, we included a measure of the percentage of hospitals in the hospital's region that adopted the technology by 2005. We also used data on operating margin and coronary CT angiography insurance reimbursement from 2005.
Finally, to control for bias in our measurement of the portion of a hospital's competitors that adopt the technology, we used the instrumental variable technique to estimate this factor. Specifically, these instruments reduce bias related to simultaneity and unobserved variables. Our instruments were (1) the median operating margin in the hospital's region in 2004, and (2) the portion of teaching hospitals in the hospital's region in 2004. Each of these characteristics captures rationales for technology adoption that are separate from any arealevel excluded variables. They were selected based on these criteria. Nonprofit hospitals are more likely than other hospitals to adopt (p < 0.05; Exhibits 1 and 2), but system membership does not appear to be a factor. Teaching hospitals constitute nearly half of all hospitals that have adopted 64-slice CT (data not shown) and have been more likely to be adopters than community hospitals (p < 0.01; Exhibit 1). Adoption also appears to have been more rapid for hospitals with heavy patient volumes, cardiac interventional capabilities, and PET ownership in 1997 (p < 0.01 for all). By 2006, 65 percent of teaching hospitals, 47 percent of hospitals with either CABG or interventional n Adjusted analyses of 64-slice CT adoption. Our adjusted analyses demonstrate that the likelihood of adopting 64-slice CT by 2006 increased with the total number of ischemic heart disease patients a hospital admitted (Exhibit 3). Hospitals with CABG or interventional cardiac catheterization capabilities were also more likely than others to adopt. Offering at least one of these services was associated with an 8.2 percentage-point increase in the probability of adopting (p < 0.05).
Study Findings

T e c h W a t c h H E A LT H A F F A I R S~We b E x c l u s i v
We found no significant relationship between Blue Cross Blue Shield reimbursement for coronary CT angiography and 64-slice CT adoption (Exhibit 3). On the contrary, we identified a weak inverse association between the availability of Medicare reimbursement for coronary CT angiography and adoption (p < 0.10). Hospitals with higher operating margins were also more likely than others to adopt 64-slice CT.
There is also evidence of a relationship between market competitiveness and adoption. Specifically, hospitals in less competitive markets were more likely to adopt than their counterparts in highly competitive markets, and this was borne out statistically for hospitals in the third and fourth HerfindahlHirschman quartiles (Exhibit 3). Further, we found no evidence that hospitals in regions with high rates of adoption in 2005 were more likely to adopt in 2006 (data not shown). This finding remained stable in our analysis using instrumental variables.
Finally, we found that adoption of 64-slice CT was more likely in teaching hospitals and hospitals with higher patient volumes. Compared to small hospitals (those in the first admissions quartile), larger hospitals were 16-29 percent more likely to adopt the technology (p < 0.05). Teaching hospitals were also more likely to adopt it than other hospitals, although this relationship was not statistically significant when the analysis was limited to hospitals that did not adopt in 2005. Institutions that owned PET scanners in 1997 were more likely to adopt than those that didn't, which suggests that some hospitals may be "technological leaders." Hospitals that owned an older-generation multislice CT scanner were also more likely to adopt the newer technology than those that did not. Our analysis did not demonstrate a statistically significant deterrent effect of certificate-of-need legislation on adoption.
Discussion
Our results support the assertion that 64-slice CT is diffusing rapidly through the health care system and that hospitals' adoption of the device is related to cardiac patient volume and hospital operating margins. We also found that adoption is poorly correlated with insurance reimbursement or market competitiveness, and that certificate-of-need legislation was ineffective in slowing down the rate of adoption.
n Implications for policy. The implications of these findings for health policy are mixed. Encouragingly, it seems economically desirable that hospitals that treat large numbers of patients with coronary artery disease and offer sophisticated cardiac treatments constitute a sizable portion of early adopters. These hospitals are best poised to reap the potential benefits of coronary CT angiographyor at least to evaluate its impact on clinical outcomes, either of which would be helpful in further guiding CMS decision making regarding reimbursement. However, much of the criticism directed at both public and private reimbursement of coronary CT angiography is motivated by the paucity of clinical evidence supporting any incremental value, and adoption has indeed been brisk in the absence of this evidence.
Although the more rapid adoption of 64-slice CT among cardiac-oriented hospitals can arguably be considered favorable from a policy perspective, the relationship between early adoption of this device and operating margin is unlikely to be favorable. Because our analyses adjust for clinical need and other hospital characteristics, this finding is perhaps the most troubling of all, because it implies that adoption is independently driven by margins-behavior that is unlikely to yield optimal resource allocation. This buttresses criticisms about the diffusion of technology being haphazard and reinforces appeals for technology assessments to review technology acquisi- NOTES: These probabilities are marginal probabilities, which means that they represent the change in the likelihood of 64-slice CT adoption when all characteristics are evaluated at their mean value and the characteristic of interest (for example, coronary artery bypass grafting [CABG] or cardiac catheterization facilities, teaching status) is increased by a factor of one unit. In the case of factors that can only take on a "yes" or "no" value, the marginal probability is the change in probability of adoption associated with shifting the factor from "no" to "yes." PET is positron-emission tomography. HRR is Hospital Referral Region. tion and procedure reimbursement decisions. 46, 47 However, it is unclear how effective these measures are in constraining adoption, as suggested by our findings regarding the ineffectiveness of certificate-of-need legislation. Moreover, Medicare's failed attempt to greatly limit reimbursement for coronary CT angiography highlights the challenges of constraining the growth of unproven interventions.
T e c h W a t c h H E A LT H A F F A I R S~We b E x c l u s i v e
The relationship between early adoption of PET and 64-slice CT is related to this. The implication is that some hospitals (or their administrators and physicians, or the patients they treat) simply have a general preference for new technology. As do our results in the analysis of operating margin, it suggests an inclination toward acquisition that is not necessarily predicated on clinical factors. Altogether, these findings may partially explain technology's role in the inexorable growth of health care costs and provide further support for the adoption of policies that promote cost-effective acquisition.
Finally, our findings regarding the relationship between Blue Cross Blue Shield and Medicare reimbursement for coronary CT angiography and adoption suggest that the former is unrelated to 64-slice CT adoption, while the latter holds a weak inverse relationship. One explanation for the Medicare finding is that coverage decisions may be sensitive to the share of hospitals acquiring the technology. For example, local Medicare carriers may be more likely to reimburse coronary CT angiography if they anticipate that few hospitals will adopt 64-slice CT and file claims. An alternative explanation is that hospitals may anticipate that insurers will cover coronary CT angiography in the future, even if the technique is not covered initially.
n Limitations. Our study has several limitations. Although the first 64-slice CT scanners came to market in 2004, the AHA only be- 48 Also, we were unable to adjust for 64-slice CT acquisitions outside of hospitals-specifically those purchased for doctors' offices and by freestanding imaging centers. 28 Their influence on hospital adoption decisions is uncertain. Our measure of market competition, the Herfindahl-Hirschman Index, is also imperfect because it does not adjust for hospitals' consolidation into systems. In addition, 20 percent of hospitals in the American Hospital Association surveys did not report whether or not they owned a 64-slice CT, and nonresponders were more likely than responders to be for-profit hospitals (28 versus 14 percent) and smaller (7,400 versus 10,300 annual admissions). Further, we were unable to determine the total number of ischemic heart disease admissions for a small number of hospitals. Also, although the American Hospital Association survey data are self-reported, there is no reason to believe that errors in reporting were systematically related to technology adoption. Finally, early PET scanner ownership is an imperfect measure of "first-mover" behavior.
T h e a d o p t i o n o f 64-slice CT has been brisk in many parts of the country, and our study suggests that hospitals' adoption decisions are related both to the total number of cardiac patients they admit and their operating margins, among other factors. The implications for policy are mixed. Adoption motivated by patient volume is good in the sense that patients' needs should be a fundamental driver of technology adoption. However, it is also of concern because only some of these hospitals are in a position to gather data on outcomes and reduce uncer- T e c h W a t c h "These findings may partially explain technology's role in the inexorable growth of health care costs and provide further support for the adoption of policies that promote cost-effective acquisition."
on September 29, 2017 by HW Team tainty about the value of the procedure. Almost certainly, there was some overacquisition of 64-slice CT by hospitals that simply assumed that it was a valuable technological advance. Further, the relationship between adoption and operating margins implies that hospitals may make acquisition decisions irrespective of clinical need-behavior that is likely to be socially undesirable, considering the opportunity cost of hospital investments and the effect that such adoption may have on the provision of imaging. Both of these findings highlight the importance of developing sensible policies regarding the diffusion of expensive new medical technologies.
